NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma
Sign Up to like & getrecommendations! Published in 2018 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2017.234
Abstract: Chemotherapy with G–CSF is used to mobilize peripheral stem cells in multiple myeloma (MM) patients, with plerixafor as a rescue strategy for poorly mobilizing patients. Preclinical studies suggested that the nonsteroidal anti-inflammatory drug meloxicam enhances… read more here.
Keywords: cd34; meloxicam enhances; meloxicam; mobilization ... See more keywords